SCHEMBL23620118

SCHEMBL23620118

COc1ncc(Cl)cc1NS(=O)(=O)c1c[nH]c2cc(Cl)ccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.45
EIF2AK4 Q9P2K8 4/20 0.44
CYP3A4 P08684 3/20 0.44
EIF2AK3 Q9NZJ5 3/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
PIK3C3 Q8NEB9 2/20 0.43
WDR5 P61964 1/20 0.42
CCR4 P51679 2/20 0.42
PIK3CA P42336 2/20 0.41
ALDH1A1 P00352 1/20 0.41
NPC1 O15118 1/20 0.40
TSHR P16473 1/20 0.40
POLB P06746 1/20 0.40
CCR2 P41597 1/20 0.40
BRD4 O60885 1/20 0.40
MAP3K20 Q9NYL2 1/20 0.40
MTOR P42345 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30991322 1.00 NR4A2 (0.45) NR4A2EIF2AK4CYP3A4EIF2AK3MEN1
SCHEMBL29829570 0.84 NR4A2 (0.43) NR4A2EIF2AK4CYP3A4EIF2AK3MEN1
SCHEMBL21596705 0.84 NR4A2 (0.43) NR4A2EIF2AK4CYP3A4EIF2AK3MEN1
SCHEMBL21596684 0.83 NR4A2 (0.42) NR4A2EIF2AK4CYP3A4EIF2AK3MEN1
SCHEMBL29829588 0.83 NR4A2 (0.42) NR4A2EIF2AK4CYP3A4EIF2AK3MEN1
SCHEMBL27037065 0.83 CCR4 (0.40) NR4A2EIF2AK4MEN1KMT2APIK3C3
SCHEMBL31510575 0.83 CCR4 (0.40) NR4A2EIF2AK4MEN1KMT2APIK3C3
SCHEMBL30991309 0.83 PRKAG1 (0.42) NR4A2EIF2AK4MEN1KMT2AWDR5
SCHEMBL30991294 0.83 MEN1 (0.44) NR4A2MEN1KMT2AWDR5ALDH1A1
SCHEMBL23620321 0.83 PRKAG1 (0.42) NR4A2EIF2AK4MEN1KMT2AWDR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US disclosed
EP-4074703-B1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2023-11-29 EP disclosed
EP-4074703-B1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2023-11-29 EP disclosed
EP-4074703-A1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB Pharma GmbH (DE) 2022-10-19 EP disclosed
EP-4074703-A1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB Pharma GmbH (DE) 2022-10-19 EP disclosed
EP-3810591-B1 PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2022-08-10 EP disclosed
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides UCB PHARMA GMBH (DE) 2021-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides GPR17, GPR18, GPR119 NR4A2 271/4885EIF2AK4 1658/4885CYP3A4 1483/4885
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides GPR17, GPR18, GPR119 NR4A2 271/4885EIF2AK4 1658/4885CYP3A4 1483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.